Nightingale Health (FRA:7XE) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:7XE Nightingale Health PLC FRA:7XE
69 GF Score
Price €0.69
GF Value €2.95
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Nightingale Health FFO?

FFO (Funds from operations) only applies to REITs.

FRA:7XE
69GF Score
Nightingale Health PLC FRA:7XE
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nightingale Health (FRA:7XE) Overvalued in 2026?

Based on GuruFocus' analysis, Nightingale Health stock appears to be undervalued. The current stock price of €0.69 is trading 76.6% below its estimated GF Value™ of €2.95. GuruFocus considers Nightingale Health to be Possible Value Trap.

Key valuation signals for FRA:7XE:

  • FFO:
  • GF Value™: €2.95 vs. price of €0.69 (76.6% below fair value)
  • GF Score™: 69/100 with 6 warning signs

No single metric tells the full story. See the FRA:7XE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nightingale Health Business Description

Other Exchanges NGHLF:USAHEALTH:Finland
Address Mannerheimintie 164a, Helsinki, FIN, 00300
Nightingale Health PLC offers a health data platform that detects disease risks. The Health Data Platform empowers individuals to take actions to prevent diseases by allowing them access to disease risk information. With its Health Data Platform, the company connects the services of healthcare actors with the preventative health needs of individuals. The company operates in Finland, Japan, the United Kingdom, Singapore, and the USA.
69GF Score

Get the complete analysis for FRA:7XE

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.69
Price
€2.95
GF Value